dc.contributor.author | Devrim, Tuba | |
dc.contributor.author | Atac, Fatih | |
dc.contributor.author | Devrim, Alparslan Kadir | |
dc.contributor.author | Balci, Mahi | |
dc.date.accessioned | 2021-01-14T18:11:07Z | |
dc.date.available | 2021-01-14T18:11:07Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Bu makale açık erişimli değildir. | en_US |
dc.identifier.issn | 0344-0338 | |
dc.identifier.uri | https://doi.org/10.1016/j.prp.2019.152774 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/12884 | |
dc.description | WOS:000523597200011 | en_US |
dc.description | PubMed: 31822365 | en_US |
dc.description.abstract | The Ubiquitin Specific Peptidase 28 (USP28) is a deubiquitinase involved in the DNA damage pathway. Recently, USP28 protein is reported to play roles in the mechanism of p53 action and could be a possible prognostic marker for bladder cancer (BCa). This study aims to explore the relation of USP28 with tumor growth and invasion, and also to investigate the interplay between USP28 and p53 in BCa. Expression levels of USP28 and p53 in human BCa (invasive and non-invasive, n = 43) and control tissues (n = 8) were evaluated by immunohistochemistry and quantitative real-time polymerase chain reaction (qPCR) profiling. The relationship between protein and gene expression levels, clinicopathologic features and prognosis were evaluated. Significant positive correlations were found between BCa tumor progression and the USP28 expression, and also between the USP28 and p53 scores (p all < 0.05). Immunohistochemistry staining percentages were strongly correlated between USP28 and p53, and also positive correlations between tumor progression and p53 expressions were determined (p all < 0.001). Interestingly, USP28 and p53 were highly expressed and correlated in BCa. Consequently, the immunohistochemistry and qPCR results reported in our study suggested the idea that USP28 in coordination with p53 could serve as a marker in BCa progression. | en_US |
dc.description.sponsorship | Scientific Research Projects Office of Kirikkale University [2018/023] | en_US |
dc.description.sponsorship | This research (project no. 2018/023) was supported by Scientific Research Projects Office of Kirikkale University. We thank our colleagues Dr. Mahmut SOZMEN and Dr. Z. Sema OZKAN, who provided insight and expertise that greatly assisted the research. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | ELSEVIER GMBH | en_US |
dc.relation.isversionof | 10.1016/j.prp.2019.152774 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Bladder cancer | en_US |
dc.subject | USP28 | en_US |
dc.subject | p53 | en_US |
dc.subject | Invasion | en_US |
dc.subject | Progression | en_US |
dc.subject | Prognosis | en_US |
dc.title | The concomitant use of USP28 and p53 to predict the progression of urothelial carcinoma of the bladder | en_US |
dc.type | article | en_US |
dc.contributor.department | KKÜ | en_US |
dc.identifier.volume | 216 | en_US |
dc.identifier.issue | 1 | en_US |
dc.relation.journal | PATHOLOGY RESEARCH AND PRACTICE | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |